← Leaderboards
Xian-Cheng Jiang
Va New York Harbor Hlthcare/Sys/Brooklyn
$8,318,221
Attributed
$8,518,221
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $884.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,518,221 · 6
VA$0 · 1
By mechanism
R01$8,118,221 · 5
R56$400,000 · 1
I01$0 · 1
Top collaborators
- Weijun Jin1 shared
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisPlasmaLipidsVery Low Density LipoproteinPreventBaseProductionMediatingPlayHepaticLiverCellsLipoproteinsInsightCholesterolKnockout GeneMacrophageAntiatherogenicRisk FactorsApolipoproteins BOverexpressionKnockout MicePathway InteractionsMetabolism
Grant awards (35)
Effect of SMSr on VLDL metabolism and atherosclerosis$0
I01 · FY2025 · VA · contact PI
Effect of SMSr on VLDL metabolism and atherosclerosis$0
I01 · FY2024 · VA · contact PI
Effect of sphingomyelin biosynthesis on atherosclerosis$486,746
R01 · FY2023 · HL · contact PI
Effect of SMSr on VLDL metabolism and atherosclerosis$0
I01 · FY2023 · VA · contact PI
Effect of sphingomyelin biosynthesis on atherosclerosis$477,521
R01 · FY2022 · HL · contact PI
Effect of SMSr on VLDL metabolism and atherosclerosis$0
I01 · FY2022 · VA · contact PI
Effect of sphingomyelin biosynthesis on atherosclerosis$480,596
R01 · FY2021 · HL · contact PI
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis$403,750
R01 · FY2021 · HL · contact PI
Effect of sphingomyelin biosynthesis on atherosclerosis$480,596
R01 · FY2020 · HL · contact PI
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis$403,750
R01 · FY2020 · HL · contact PI
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis$403,750
R01 · FY2019 · HL · contact PI
PLTP as a target for lowering VLDL production$0
I01 · FY2019 · VA · contact PI
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis$403,750
R01 · FY2018 · HL · contact PI
PLTP as a target for lowering VLDL production$0
I01 · FY2018 · VA · contact PI
PLTP as a target for lowering VLDL production$0
I01 · FY2017 · VA · contact PI
PLTP as a target for lowering VLDL production$0
I01 · FY2016 · VA · contact PI
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2015 · VA · contact PI
Hepatic PLTP as a target for lowering LDL-c$400,000
R56 · FY2014 · HL
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2014 · VA · contact PI
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2013 · VA · contact PI
The Effect of SPT Deficiency on Atherosclerosis$0
I01 · FY2012 · VA · contact PI
The effect of macrophage sphingomyelin synthase (SMS) on atherosclerosis$429,280
R01 · FY2010 · HL · contact PI
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis$351,000
R01 · FY2010 · HL · contact PI
The effect of macrophage sphingomyelin synthase (SMS) on atherosclerosis$423,358
R01 · FY2009 · HL · contact PI
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis$351,000
R01 · FY2009 · HL · contact PI
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis$351,000
R01 · FY2008 · HL · contact PI
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis$350,250
R01 · FY2007 · HL · contact PI
The role of PLTP in BLp metabolism and atherogenesis$306,000
R01 · FY2005 · HL
The role of PLTP in BLp metabolism and atherogenesis$306,000
R01 · FY2004 · HL
THE ROLE OF PLASMA SPHINGOMYELIN IN ATHEROSCLEROSIS$267,750
R01 · FY2004 · HL
The role of PLTP in BLp metabolism and atherogenesis$306,000
R01 · FY2003 · HL
THE ROLE OF PLASMA SPHINGOMYELIN IN ATHEROSCLEROSIS$267,750
R01 · FY2003 · HL
The role of PLTP in BLp metabolism and atherogenesis$304,000
R01 · FY2002 · HL
THE ROLE OF PLASMA SPHINGOMYELIN IN ATHEROSCLEROSIS$266,000
R01 · FY2002 · HL
THE ROLE OF PLASMA SPHINGOMYELIN IN ATHEROSCLEROSIS$298,374
R01 · FY2001 · HL